Flutriciclamide (18F)

N/A

Report date: 2025/11/24 17:27:21
NME

Base Information

Drug NameFlutriciclamide (18F)
Drug Alias Nameflutriciclamide [18F]Fluorine-18-GEH-120714Fluorine-18-flutriciclamideGE-18018F-GE-180 +[15] 
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionTranslocator protein modulators
TargetsTranslocator protein
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-Remitting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGe Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGe Healthcare
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis, Relapsing-Remitting

Other Information

ATC CodeN/A
Related LinksN/A